Aptose Biosciences Stock Target Price and Analyst Consensus
| APTO Stock | USD 1.23 0.04 3.15% |
The current analyst and expert consensus on Aptose Biosciences is Strong Buy, with only one strong buy opinion. The current projected Aptose Biosciences target price consensus is 19.71 with 3 analyst opinions. The most common way Aptose Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Aptose Biosciences executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Aptose Biosciences. We encourage you to use your own analysis of Aptose Biosciences to validate this buy or sell advice. Aptose Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Aptose Biosciences target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Aptose Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
Lowest Forecast 17.94 | Highest Forecast 21.88 | Target Price 19.71 |
Aptose |
It's important to approach Aptose Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Aptose Biosciences price targets
Aptose Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Aptose Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Aptose Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Aptose Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Aptose Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Aptose Biosciences is a key component of Aptose Biosciences valuation and have some predictive power on the future returns of a Aptose Biosciences.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptose Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Blockchain Invested a lot of shares | |
 | Manufacturing Invested over 40 shares | |
 | Baby Boomer Prospects Invested over 50 shares | |
 | Artificial Intelligence Invested few shares | |
 | Momentum Invested over 70 shares | |
 | Investor Favorites Invested over 200 shares | |
Check out Macroaxis Advice on Aptose Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Aptose Stock analysis
When running Aptose Biosciences' price analysis, check to measure Aptose Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptose Biosciences is operating at the current time. Most of Aptose Biosciences' value examination focuses on studying past and present price action to predict the probability of Aptose Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptose Biosciences' price. Additionally, you may evaluate how the addition of Aptose Biosciences to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
The data published in Aptose Biosciences' official financial statements usually reflect Aptose Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Aptose Biosciences. For example, before you start analyzing numbers published by Aptose accountants, it's critical to develop an understanding of what Aptose Biosciences' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Aptose Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aptose Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Aptose Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aptose Biosciences. Please utilize our Beneish M Score to check the likelihood of Aptose Biosciences' management manipulating its earnings.